Non-human primate models of human respiratory infections.


Journal

Molecular immunology
ISSN: 1872-9142
Titre abrégé: Mol Immunol
Pays: England
ID NLM: 7905289

Informations de publication

Date de publication:
07 2021
Historique:
received: 17 02 2021
revised: 03 04 2021
accepted: 12 04 2021
pubmed: 26 4 2021
medline: 16 6 2021
entrez: 25 4 2021
Statut: ppublish

Résumé

Respiratory pathogens represent a great burden for humanity and a potential source of new pandemics, as illustrated by the recent emergence of coronavirus disease 2019 (COVID-19). In recent decades, biotechnological advances have led to the development of numerous innovative therapeutic molecules and vaccine immunogens. However, we still lack effective treatments and vaccines against many respiratory pathogens. More than ever, there is a need for a fast, predictive, preclinical pipeline, to keep pace with emerging diseases. Animal models are key for the preclinical development of disease management strategies. The predictive value of these models depends on their ability to reproduce the features of the human disease, the mode of transmission of the infectious agent and the availability of technologies for monitoring infection. This review focuses on the use of non-human primates as relevant preclinical models for the development of prevention and treatment for human respiratory infections.

Identifiants

pubmed: 33895579
pii: S0161-5890(21)00127-9
doi: 10.1016/j.molimm.2021.04.010
pmc: PMC8062575
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-164

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Eur Respir J. 2009 May;33(5):974-85
pubmed: 19213792
Appl Environ Microbiol. 2019 Aug 14;85(17):
pubmed: 31253680
Virulence. 2013 Nov 15;4(8):847-58
pubmed: 24225380
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Lancet. 2003 Jul 26;362(9380):263-70
pubmed: 12892955
Infect Immun. 2010 Jul;78(7):2946-55
pubmed: 20385751
Lancet Infect Dis. 2013 Sep;13(9):785-96
pubmed: 23969216
Clin Infect Dis. 2001 Sep 15;33(6):792-6
pubmed: 11512084
Lab Invest. 2003 Aug;83(8):1201-9
pubmed: 12920249
Microb Pathog. 2010 Dec;49(6):336-47
pubmed: 20674736
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16598-603
pubmed: 24062443
Antimicrob Agents Chemother. 2011 Nov;55(11):4961-70
pubmed: 21844317
J Comp Pathol. 1994 Feb;110(2):207-12
pubmed: 8040386
Infect Immun. 2014 Jun;82(6):2400-4
pubmed: 24664509
J Infect Dis. 1993 Mar;167(3):553-61
pubmed: 8440926
N Engl J Med. 2020 Aug 6;383(6):590-592
pubmed: 32402155
Tuberculosis (Edinb). 2019 May;116S:S11-S18
pubmed: 31072689
Ann N Y Acad Sci. 1977 Mar 4;284:264-71
pubmed: 101109
Science. 2020 Aug 14;369(6505):818-823
pubmed: 32616673
Infect Immun. 1979 Dec;26(3):1009-13
pubmed: 118925
J Med Primatol. 2009 Aug;38(4):236-40
pubmed: 19239572
Science. 1989 May 12;244(4905):713-6
pubmed: 2524098
J Infect Dis. 1996 Aug;174(2):256-61
pubmed: 8699052
Virol J. 2020 Aug 18;17(1):125
pubmed: 32811514
J Immunol. 2018 Nov 1;201(9):2541-2548
pubmed: 30348659
Pediatr Res. 2005 Jul;58(1):10-4
pubmed: 15774850
Toxicol Pathol. 2006;34(5):599-608
pubmed: 17067945
Inhal Toxicol. 2008 Sep;20(11):1029-36
pubmed: 18720170
N Engl J Med. 2020 Oct 15;383(16):1544-1555
pubmed: 32722908
Am J Anat. 1975 Jan;142(1):107-21
pubmed: 804810
J Virol. 2007 Feb;81(3):1162-73
pubmed: 17108019
Nat Microbiol. 2021 Jan;6(1):73-86
pubmed: 33340034
J Infect Dis. 1998 Jul;178(1):53-60
pubmed: 9652423
Animal Model Exp Med. 2020 Mar 30;3(1):93-97
pubmed: 32318665
J Neurosci. 2007 Aug 15;27(33):8857-65
pubmed: 17699667
Toxicol Pathol. 1991;19(4 Pt 1):321-36
pubmed: 1813979
J Pharmacol Toxicol Methods. 2004 Jan-Feb;49(1):39-55
pubmed: 14670693
Front Immunol. 2018 Jun 19;9:1394
pubmed: 29971068
Antimicrob Agents Chemother. 2013 Sep;57(9):4237-4244
pubmed: 23796926
Cell. 2021 Mar 4;184(5):1188-1200.e19
pubmed: 33577765
Toxicol Pathol. 2007 Jan;35(1):3-14
pubmed: 17325967
Nat Immunol. 2021 Jan;22(1):86-98
pubmed: 33235385
Nat Rev Immunol. 2011 Aug 05;11(9):625-32
pubmed: 21818124
Nature. 2020 Oct;586(7830):509-515
pubmed: 32967005
Antimicrob Agents Chemother. 1978 Feb;13(2):284-8
pubmed: 417672
Vaccine. 1993 Nov;11(14):1395-404
pubmed: 8310760
J Med Virol. 1978;2(1):45-59
pubmed: 210254
Infect Immun. 2015 May;83(5):2082-8
pubmed: 25754201
J Med Primatol. 2006 Jun;35(3):113-22
pubmed: 16764668
J Gen Virol. 2001 Nov;82(Pt 11):2663-2674
pubmed: 11602778
Vaccine. 2007 Apr 12;25(15):2823-31
pubmed: 17254671
Semin Nucl Med. 2016 Jan;46(1):5-19
pubmed: 26687853
PLoS One. 2019 Jul 22;14(7):e0220196
pubmed: 31329652
J Gen Virol. 2007 Feb;88(Pt 2):530-535
pubmed: 17251571
J Infect Dis. 2015 Dec 15;212(12):1904-13
pubmed: 26198719
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E1026-33
pubmed: 26787852
Tuberculosis (Edinb). 2016 Jan;96:1-12
pubmed: 26786648
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6212-6
pubmed: 15073334
Immunity. 2020 Aug 18;53(2):248-263
pubmed: 32717182
J Infect Dis. 2012 Jul 1;206(1):56-62
pubmed: 22529314
PLoS One. 2012;7(2):e30631
pubmed: 22319574
Front Biosci. 2001 Aug 01;6:D877-89
pubmed: 11502489
J Exp Med. 1946 Jul 31;84(2):113-25
pubmed: 19871557
Virulence. 2013 Nov 15;4(8):707-15
pubmed: 24104465
J Virol. 2003 Nov;77(21):11303-11
pubmed: 14557616
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
Am J Pathol. 1978 Dec;93(3):771-91
pubmed: 362946
Infect Immun. 1974 Jan;9(1):101-5
pubmed: 4202882
Infect Immun. 2015 Mar;83(3):852-62
pubmed: 25547788
Nat Methods. 2015 May;12(5):427-32
pubmed: 25751144
Respir Med. 2009 Nov;103(11):1738-45
pubmed: 19540100
J Virol. 2002 Jan;76(2):582-90
pubmed: 11752149
J Infect Dis. 2017 Jul 1;216(1):117-124
pubmed: 28535276
Comp Med. 2008 Feb;58(1):68-75
pubmed: 19793459
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
PLoS One. 2017 Mar 8;12(3):e0171906
pubmed: 28273087
Chest. 1976 Jul;70(1 Suppl):134-7
pubmed: 939128
J Comp Pathol. 2014 Jul;151(1):83-112
pubmed: 24581932
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30830861
Nat Med. 2014 Jan;20(1):75-9
pubmed: 24336248
Tuberculosis (Edinb). 2017 Jul;105:86-95
pubmed: 28610792
J Aerosol Med. 1997 Winter;10(4):319-29
pubmed: 10175962
Front Microbiol. 2019 May 03;10:873
pubmed: 31130923
J Pharmacol Toxicol Methods. 2007 Jan-Feb;55(1):96-102
pubmed: 16737832
Proc Natl Acad Sci U S A. 1967 Apr;57(4):933-40
pubmed: 5231356
Antiviral Res. 2016 May;129:120-129
pubmed: 26923881
Comp Med. 2019 Dec 1;69(6):520-534
pubmed: 31896389
Nature. 2014 Mar 13;507(7491):201-6
pubmed: 24499818
J Clin Invest. 2019 Dec 2;129(12):5254-5260
pubmed: 31479428
Vaccine. 2015 Aug 26;33(36):4472-8
pubmed: 26206269
Science. 1932 Oct 7;76(1971):330-1
pubmed: 17799572
Cell Host Microbe. 2020 Jul 8;28(1):124-133.e4
pubmed: 32485164
Proc Soc Exp Biol Med. 1956 Jul;92(3):544-9
pubmed: 13359460
Influenza Other Respir Viruses. 2013 Sep;7(5):872-86
pubmed: 23331969
Mol Immunol. 2015 Oct;67(2 Pt A):142-52
pubmed: 25934435
J Immunol. 2017 Feb 15;198(4):1616-1626
pubmed: 28062701
Am J Physiol Lung Cell Mol Physiol. 2013 Apr 15;304(8):L530-9
pubmed: 23418091
Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620947303
pubmed: 32741202
Immunity. 2016 Jun 21;44(6):1379-91
pubmed: 27287409
J Pharmacol Toxicol Methods. 2014 Jul-Aug;70(1):62-5
pubmed: 24857836
PLoS Pathog. 2010 Feb 05;6(2):e1000756
pubmed: 20140198
J Med Primatol. 2012 Jun;41(3):191-201
pubmed: 22429048
Vaccine. 2017 Jan 11;35(3):469-480
pubmed: 27908639
Viruses. 2021 Feb 22;13(2):
pubmed: 33671829
Cell. 2019 Mar 7;176(6):1420-1431.e17
pubmed: 30849373
Infect Immun. 2008 Dec;76(12):5588-97
pubmed: 18794281
PLoS One. 2014 Apr 30;9(4):e95456
pubmed: 24787744
J Biophotonics. 2016 Sep;9(9):868-78
pubmed: 26846880
Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1081-2
pubmed: 15306393
Dev Comp Immunol. 2019 Mar;92:212-222
pubmed: 30513304
Infect Immun. 2003 Oct;71(10):5831-44
pubmed: 14500505
J Infect Dis. 2014 Jan 15;209(2):236-42
pubmed: 24218506
Infect Immun. 2012 Apr;80(4):1530-6
pubmed: 22252879
N Engl J Med. 2006 Aug 17;355(7):666-74
pubmed: 16914702
PLoS Pathog. 2020 Sep 18;16(9):e1008903
pubmed: 32946524
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
J Infect Dis. 2012 Sep 15;206(6):902-6
pubmed: 22807521
Tuberculosis (Edinb). 2016 Jan;96:141-9
pubmed: 26723465
J Infect Dis. 2020 May 11;221(Suppl 4):S419-S430
pubmed: 31687756
J Med Primatol. 2002 Apr;31(2):61-73
pubmed: 12110049
N Engl J Med. 2013 Apr 18;368(16):1560-2
pubmed: 23550601
Comp Med. 2016;66(5):412-419
pubmed: 27780009
Antiviral Res. 2015 May;117:75-98
pubmed: 25746173
J Virol. 2013 Dec;87(24):13706-18
pubmed: 24109221
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):E3119-E3128
pubmed: 28348219
Am J Dis Child. 1986 Jun;140(6):543-6
pubmed: 3706232
Am J Physiol Lung Cell Mol Physiol. 2011 Aug;301(2):L148-56
pubmed: 21571908
PLoS One. 2010 Mar 10;5(3):e9611
pubmed: 20224771
N Engl J Med. 2017 Feb 9;376(6):584-594
pubmed: 28177862
J Virol. 2007 Nov;81(21):11817-27
pubmed: 17715226
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Infect Immun. 2013 Aug;81(8):2909-19
pubmed: 23716617
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595
pubmed: 32571934
PLoS Negl Trop Dis. 2018 Nov 21;12(11):e0006978
pubmed: 30462637
Infect Immun. 2005 Jun;73(6):3636-45
pubmed: 15908393
J Toxicol Environ Health. 1986;17(2-3):163-74
pubmed: 3959107
Semin Immunol. 2014 Oct;26(5):357-68
pubmed: 24486056
Sci Rep. 2018 Aug 16;8(1):12297
pubmed: 30115990
Viruses. 2010;2(8):1530-1563
pubmed: 21442033
Nat Microbiol. 2016 Nov 28;2:16226
pubmed: 27892925
Am J Pathol. 2010 Mar;176(3):1346-54
pubmed: 20093487
J Med Primatol. 2010 Feb;39(1):58-70
pubmed: 19900170
Am J Respir Cell Mol Biol. 2014 Sep;51(3):334-43
pubmed: 24828366
Pathogens. 2014 Oct 21;3(4):845-74
pubmed: 25436508
mBio. 2019 Dec 17;10(6):
pubmed: 31848292
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5636-44
pubmed: 27601645
Infect Immun. 2009 Oct;77(10):4631-42
pubmed: 19620341
J Virol. 2007 Jan;81(2):813-21
pubmed: 17079315
PLoS Med. 2006 Dec;3(12):e525
pubmed: 17194199
Nat Med. 2019 Feb;25(2):255-262
pubmed: 30664782
Arch Pathol Lab Med. 1996 Feb;120(2):156-63
pubmed: 8712895
Clin Vaccine Immunol. 2010 Dec;17(12):1875-80
pubmed: 20943876
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD006602
pubmed: 23633336
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4970-5
pubmed: 24599590
Cell Host Microbe. 2020 May 13;27(5):704-709.e2
pubmed: 32259477
PLoS One. 2012;7(5):e37220
pubmed: 22623997
J Virol. 2002 Nov;76(22):11561-9
pubmed: 12388717
J Virol. 2015 Jun;89(11):6131-5
pubmed: 25810539
Science. 2020 May 29;368(6494):1012-1015
pubmed: 32303590
Nature. 2020 Jul;583(7818):830-833
pubmed: 32380511
Am J Pathol. 1969 Feb;54(2):167-85
pubmed: 4974722
PLoS Pathog. 2007 Jan;3(1):e5
pubmed: 17222058
J Virol. 2014 Apr;88(8):3997-4007
pubmed: 24453366
Infect Immun. 2018 Jan 22;86(2):
pubmed: 28947646
Nature. 2003 May 15;423(6937):240
pubmed: 12748632
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Vaccine. 2011 Jul 26;29(33):5495-501
pubmed: 21624422
Vaccine. 2005 Jan 11;23(8):1079-84
pubmed: 15620482
J Med Primatol. 2011 Feb;40(1):6-17
pubmed: 20722770
Am J Respir Crit Care Med. 2017 Sep 1;196(5):609-620
pubmed: 28614669
Infect Immun. 2006 Feb;74(2):1113-20
pubmed: 16428759
Respir Med. 2011 Jul;105(7):959-71
pubmed: 21356587
J Virol. 2005 May;79(9):5833-8
pubmed: 15827197
Vaccine. 1990 Apr;8(2):164-8
pubmed: 2336876
J Med Primatol. 1978;7(2):122-4
pubmed: 712806
Virology. 2010 Nov 25;407(2):178-84
pubmed: 20822788
Infect Immun. 2014 Feb;82(2):864-72
pubmed: 24478099
Nat Med. 2004 Apr;10(4):368-73
pubmed: 15034574
PLoS One. 2015 Dec 07;10(12):e0143580
pubmed: 26641081
Vaccine. 2012 Jan 20;30(5):959-68
pubmed: 22119594
Am J Pathol. 2007 Apr;170(4):1136-47
pubmed: 17392154
Clin Microbiol Rev. 1997 Jan;10(1):35-66
pubmed: 8993858
Am J Epidemiol. 1969 Apr;89(4):422-34
pubmed: 4305198
Nature. 2020 Sep;585(7826):584-587
pubmed: 32698191
Viruses. 2016 Jun 14;8(6):
pubmed: 27314379
J Med Primatol. 2012 Feb;41(1):60-6
pubmed: 21967372
J Virol. 2005 Jan;79(2):884-95
pubmed: 15613317
Am J Respir Crit Care Med. 2007 Jan 1;175(1):22-31
pubmed: 17023733
J Immunol. 2017 Jul 15;199(2):383-388
pubmed: 28696328
J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2861-2862
pubmed: 31706498
Oncotarget. 2016 Mar 8;7(10):10990-1001
pubmed: 26934329
Clin Infect Dis. 2020 Nov 19;71(16):2139-2149
pubmed: 32472679
Alcohol Clin Exp Res. 2013 Jun;37(6):969-77
pubmed: 23414480
J Gen Virol. 2020 Dec;101(12):1229-1241
pubmed: 32975505
J Infect Dis. 2014 Aug 15;210(4):604-10
pubmed: 24526741
Biologicals. 2009 Jun;37(3):152-9
pubmed: 19394861
Immunol Rev. 2015 Mar;264(1):60-73
pubmed: 25703552
Pediatr Dev Pathol. 1999 Jul-Aug;2(4):316-26
pubmed: 10347274
ILAR J. 2017 Dec 1;58(2):269-280
pubmed: 29216343
Science. 2020 Aug 14;369(6505):812-817
pubmed: 32434946
J Neurosurg Anesthesiol. 2013 Jan;25(1):8-15
pubmed: 22990390
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
Curr Opin Virol. 2015 Aug;13:123-9
pubmed: 26184451
Cold Spring Harb Perspect Med. 2014 Sep 11;4(12):a018564
pubmed: 25213189
Inhal Toxicol. 2017 Sep;29(11):506-515
pubmed: 29224407
Science. 2020 May 15;368(6492):
pubmed: 32409444
N Engl J Med. 2005 Apr 28;352(17):1749-59
pubmed: 15858184
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):787-92
pubmed: 24277828
Vaccine. 2016 Feb 10;34(7):950-6
pubmed: 26772634
Sci Transl Med. 2014 Oct 22;6(259):259ra146
pubmed: 25338757
PLoS Negl Trop Dis. 2017 Apr 7;11(4):e0005532
pubmed: 28388650
J Infect Dis. 2014 Apr 1;209 Suppl 1:S20-3
pubmed: 24626867
J Aerosol Med. 2005 Summer;18(2):225-35
pubmed: 15966777
Clin Vaccine Immunol. 2015 Nov 11;23(1):47-54
pubmed: 26561389
Nature. 2020 Sep;585(7824):268-272
pubmed: 32396922
Health Technol Assess. 2008 Dec;12(36):iii, ix-x, 1-86
pubmed: 19049692
Lab Invest. 2001 Dec;81(12):1581-600
pubmed: 11742030
Front Immunol. 2018 Apr 10;9:709
pubmed: 29692778
Aerosol Sci Technol. 2016;50(11):1167-1179
pubmed: 28413241
J Med Virol. 2002 May;67(1):92-100
pubmed: 11920822
Virology. 2004 Dec 5;330(1):8-15
pubmed: 15527829
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7553-8
pubmed: 19383786
Indian J Exp Biol. 1998 Aug;36(8):758-62
pubmed: 9838875
Clin Infect Dis. 2013 Oct;57(8):1069-77
pubmed: 23876395
Nat Med. 2004 Dec;10(12 Suppl):S88-97
pubmed: 15577937
PLoS Pathog. 2013 Aug;9(8):e1003501
pubmed: 23966854
PLoS One. 2014 Sep 22;9(9):e107951
pubmed: 25243851
J Infect Dis. 2018 Mar 28;217(8):1231-1236
pubmed: 29346585
Emerg Microbes Infect. 2019;8(1):760-772
pubmed: 31130102
Lancet. 2003 May 24;361(9371):1773-8
pubmed: 12781536
Lancet. 2004 Aug 21-27;364(9435):709-21
pubmed: 15325838
Nature. 2019 Jun;570(7762):528-532
pubmed: 31168092
Sci Rep. 2018 Mar 19;8(1):4801
pubmed: 29556081
Am J Respir Crit Care Med. 2015 May 1;191(9):1040-9
pubmed: 25730467
Nat Commun. 2021 Jan 14;12(1):372
pubmed: 33446655
Cell Res. 2020 Aug;30(8):670-677
pubmed: 32636454
PLoS Pathog. 2009 Oct;5(10):e1000604
pubmed: 19798428
Front Microbiol. 2018 Apr 09;9:691
pubmed: 29686661
Trends Microbiol. 2007 Oct;15(10):462-8
pubmed: 17920273
J Biomed Sci. 2019 Oct 23;26(1):84
pubmed: 31640786
Nature. 2020 Sep;585(7824):273-276
pubmed: 32516797
JAMA. 2003 Jan 8;289(2):179-86
pubmed: 12517228
Lancet Infect Dis. 2005 Nov;5(11):685-94
pubmed: 16253886
Signal Transduct Target Ther. 2020 Oct 19;5(1):157
pubmed: 32814760
PLoS One. 2008 Aug 21;3(8):e2985
pubmed: 18716658
Proc Soc Exp Biol Med. 1970 Dec;135(3):717-23
pubmed: 4992080
J Virol. 2000 Oct;74(19):9317-21
pubmed: 10982380
J Med Virol. 1977;1(3):157-62
pubmed: 416176

Auteurs

Julien Lemaitre (J)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Thibaut Naninck (T)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Benoît Delache (B)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Justina Creppy (J)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France; Centre d'Etude des Pathologies Respiratoires, INSERM U1100, Université de Tours, Tours, France.

Philippe Huber (P)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Marion Holzapfel (M)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Camille Bouillier (C)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Vanessa Contreras (V)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Frédéric Martinon (F)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Nidhal Kahlaoui (N)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Quentin Pascal (Q)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Sabine Tricot (S)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Frédéric Ducancel (F)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Laurent Vecellio (L)

Centre d'Etude des Pathologies Respiratoires, INSERM U1100, Université de Tours, Tours, France; Plateforme Scientifique et Technique Animaleries (PST-A), Université de Tours, Tours, France.

Roger Le Grand (R)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Pauline Maisonnasse (P)

Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France. Electronic address: pauline.maisonnasse@cea.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH